Wordt geladen...
Molecular Mechanism of Altered Ezetimibe Disposition in Nonalcoholic Steatohepatitis
Ezetimibe (EZE) lowers serum lipid levels by blocking cholesterol uptake in the intestine. Disposition of EZE and its pharmacologically active glucuronide metabolite (EZE-GLUC) to the intestine is dependent on hepatobiliary efflux. Previous studies suggested that hepatic transporter expression and f...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The American Society for Pharmacology and Experimental Therapeutics
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3286272/ https://ncbi.nlm.nih.gov/pubmed/22112382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.111.041095 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|